Skip to main content

Tang Kevin C's Form 4 filing

Aurinia Pharmaceuticals Inc.AUPH · filed Jun 2, 2026

Accession no.
0001178579-26-000004
Filed
Jun 2, 2026, 9:54 PM ET
Trade date
May 29-Jun 2, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market purchases total $12.5M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tang Kevin CCIK 0001178579Director, Officer (Chief Executive Officer), 10% Owner
Tang Capital Management LLCCIK 000123262110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 29, 2026Common SharesPPurchaseAcquired+2,299$15.35F1+$35,289.6512,231,799Indirect
May 29, 2026Common SharesPPurchaseAcquired+262,682$15.31F3+$4,021,661.4212,494,481Indirect
Jun 1, 2026Common SharesPPurchaseAcquired+343,521$15.28F4+$5,249,000.8812,838,002Indirect
Jun 1, 2026Common SharesPPurchaseAcquired+99$15.34F5+$1,518.6612,838,101Indirect
Jun 2, 2026Common SharesPPurchaseAcquired+206,005$15.28F6+$3,147,756.413,044,106Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2026Common SharesJOtherAcquired+1,000,000$1.65+$16,50010,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $15.33 to $15.38. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 6.

Referenced by the price of 1 transaction in Table I.

F3

These shares were purchased in multiple transactions ranging from $15.05 to $15.37.

Referenced by the price of 1 transaction in Table I.

F4

These shares were purchased in multiple transactions ranging from $14.97 to $15.50.

Referenced by the price of 1 transaction in Table I.

F5

These shares were purchased at $15.34.

Referenced by the price of 1 transaction in Table I.

F6

These shares were purchased in multiple transactions ranging from $15.00 to $15.40.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)